CTRI/2024/07/071736尚未招募Unknown
Acute toxicities and dosimetry associated with conventional and hypo fractionated adjuvant radiation in carcinoma breast. - NI
Dr.Harikrishna Suresh0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients who are above the age of 18 years diagnosed with early stage or locally advanced carcinoma breast, has undergone mastectomy or breast conservative surgery who will be required to undergo adjuvant radiotherapy.
排除标准
- •PATIENTS WITH METASTATIC DISEASE
- •PATIENTS WITH RELAPSE
- •MENTALLY CHALLENGED PATIENTS
研究者
相似试验
尚未招募
2 期
Comparison of Response and Acute Toxicities of Concurrent Chemoradiation with Weekly Cisplatin Vs. Paclitaxel/Carboplatin in Locally Advanced Squamous Cell Carcinoma of Head & Neck: A Short-term Phase III Clinical Trial.C76.0Head, face and neckDRKS00012877Dr. Md Shuayb, MBBS, MSc, FCPS, Specialist, Oncology & Radiotherapy Centre, Square Hospitals Ltd.100
尚未招募
2 期
High dose radiotherapy in the treatment of advanced carcinoma cervix -a prospective studyCTRI/2023/07/055597Dr Anjan Bera
已完成
2 期
Comparison of two different Radiotherapy techniques for the treatment of Cervical CancerCTRI/2018/05/014118GHRITASHEE BORA30
已完成
不适用
Determination of the toxicity of standard dose cetuximab together with concurrent individualised, isotoxic accelerated radiotherapy and cisplatin - vinorelbine for patients with stage III non-small cell lung cancer (NSCLC): a phase I study.Non-small cell lung cancer10038666NL-OMON35459MAASTRO clinic18
进行中（未招募）
不适用
Phase I/II study: on the toxicity and effects of combining the p53 synthetic long peptides vaccine with either Imiquimod or Interferon-alfa to induce polarized p53-specific immunity in patients treated for colorectal cancer - p53-SLP vaccine in combination with Imiquimod or IFNaEUCTR2008-004611-35-NLeiden University Medical Center